ALLOX — Pre-seed

ALLOX, a techbio spin-off of the Centre for Genomic Regulation that designs drugs targeting allosteric sites on 'undruggable' proteins, announced its incorporation and an undisclosed pre-seed round from Asabys Partners' Sabadell Asabys II fund. The financing will set up the initial team and facilities ahead of a larger round planned in 18 to 24 months.